[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"dumping-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:dumping-syndrome":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,43,75],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100640243","dumping-syndrome-after-esophagectomy-100640243",false,"NCT07605481","Dumping Syndrome After Esophagectomy","Prospective Observational Study on the Utility of Continuous Glucose Monitoring for the Diagnosis of Dumping Syndrome After Esophagectomy","Inclusion Criteria:\n\n-1. aged 18 or older. 2. people who underwent esophagectomy and gastric tube reconstruction for esophageal cancer.\n\n3\\. Sigstad score of 7 or higher.\n\nExclusion Criteria:\n\n* 1\\. Diabetes with autonomic neuropathy. 2. Inability to complete the diagnostic procedure (e.g., cognitive decline). 3. Refusal to participate.","ALL","18 Years",{"count":19,"type":20},30,"ESTIMATED","OBSERVATIONAL","Background:\n\nDumping syndrome is a common complication for patients who have undergone surgery for esophageal cancer. It occurs when food moves too quickly from the stomach (or the reconstructed gastric tube) into the small intestine. This rapid movement causes various symptoms such as bloating, abdominal pain, dizziness, rapid heartbeat, and sweating. Sometimes, it leads to \"late dumping,\" where blood sugar levels drop significantly, causing tremors, cold sweats, and fatigue. Currently, there is no standardized tool to easily diagnose this condition after esophagectomy.\n\nPurpose of the Study:\n\nThe objective of this study is to evaluate the effectiveness of Continuous Glucose Monitoring (CGM) in diagnosing dumping syndrome. CGM is a small, wearable sensor that tracks glucose levels in real-time. The investigators aim to determine whether CGM can serve as a valuable tool for the early detection of dumping syndrome in patients who have undergone esophagectomy.",[24,25,26],"Esophagectomy","Dumping Syndrome","Continous Glucose Measurement",[28,29],"esophagectomy","dumping syndrome","RECRUITING","2026-05-21",{"date":33,"type":34},"2026-05-26","ACTUAL",{"date":36,"type":20},"2026-06-15",{"date":38,"type":20},"2028-12-31",{"name":40,"class":41},"Samsung Medical Center","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":42},"100626828","continuous-glucose-monitoring-with-ican-i3-in-post-bariatric-patients-with-late-dumping-syndrome-100626828","NCT07440706","Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome","A Prospective Randomized Study Evaluating the Efficacy and Safety of the iCan i3 Continuous Glucose Monitoring System in Post-Bariatric Patients With Late Dumping Syndrome","iCan3 Dumping","Inclusion Criteria:\n\n* Age 18-65 years\n* History of Roux-en-Y gastric bypass ≥12 months\n* Clinical diagnosis of late dumping syndrome\n* Stable body weight (\\\u003C5% variation in last 3 months)\n* Ability to provide informed consent\n\nExclusion Criteria:\n\n* Diagnosis of diabetes mellitus under treatment\n* Use of antidiabetic medications (except acarbose)\n* Pregnancy or breastfeeding\n* Cognitive impairment affecting study participation\n* Known hypersensitivity to CGM adhesives\n* Conditions increasing risk of hypoglycemia (e.g., prolonged fasting)\n* Active or prior malignancy\n* Need for imaging procedures during study period","65 Years",{"count":53,"type":20},60,"INTERVENTIONAL",[56],"NA","Late dumping syndrome is a common complication following Roux-en-Y gastric bypass, characterized by postprandial hypoglycemia with significant impact on patient safety and quality of life. Traditional capillary glucose monitoring has limited ability to detect rapid glycemic fluctuations.\n\nThis prospective randomized study aims to evaluate the efficacy and safety of the iCan i3 continuous glucose monitoring (CGM) system compared to conventional capillary glucose monitoring in detecting hypoglycemic events in post-bariatric patients with late dumping syndrome.\n\nParticipants will be randomized into two groups: one using CGM and one using standard fingerstick monitoring, and followed for 60 days. Clinical outcomes, hypoglycemia frequency, symptom correlation, and quality of life will be assessed.",[25,59],"Post-bariatric Hypoglycemia",[61,62,63,64,65],"Late Dumping Syndrome","Post-Bariatric Hypoglycemia","Continuous Glucose Monitoring","Roux-en-Y Gastric Bypass","Hypoglycemia","2026-02-23",{"date":68,"type":34},"2026-02-27",{"date":70,"type":34},"2025-10-15",{"date":72,"type":20},"2026-12-31",{"name":74,"class":41},"Kaiser Clinic and Hospital",{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":16,"minAge":83,"maxAge":84,"enrollmentInfo":85,"targetDuration":4,"studyType":54,"phases":87,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":105},"100402586","dumping-syndrome-and-esophageal-atresia-100402586","NCT04522193","Dumping Syndrome and Esophageal Atresia","Physiopathology of Dumping Syndrome in Esophageal Atresia","DUMTORING","Inclusion Criteria:\n\n* Patients operated at birth for Oesophageal atresia type C\n* Aged from 2 to 3 months at inclusion\n* Off prokinetic treatment (suspended for at least 72 hours) before monitoring\n\nExclusion Criteria:\n\n* History of dumping syndrome of other cause (microgastria, fundoplication, dysautonomia..)\n* History of any disease that can modify glycemic regulation (hyperinsulinism, neonatal diabete)\n* Treatment that can modify gastric motility","2 Months","3 Months",{"count":86,"type":20},15,[56],"Dumping syndrome (DS) is frequent in oesophageal atresia (29%). In causing hypoglycaemia, it can be dangerous for neonates. Mechanisms of DS are actually partialy understood. This is also an affection difficult to diagnose, because it only occurs after meals and can be inconstantly present. To date, their is only symptomatic treatment for DS. This study aims to understand its pathological mechanisms so as to better treat it and avoid its consequences. Oesophageal atresia patients enrolled in this study will benefit from a continuous glycemic monitoring, a continuous cardiac monitoring, and an a gastric emptying scintigraphy at the age of 3 months",[90,25],"Oesophageal Atresia",[92,93,94,95],"Oesophageal dysmotility","Oesophageal atresia","Post prandial hypoglycaemia","Gastric emptying troubles","2025-12-17",{"date":98,"type":34},"2025-12-23",{"date":100,"type":34},"2024-02-23",{"date":102,"type":20},"2026-11",{"name":104,"class":41},"University Hospital, Lille",2]